Literature DB >> 23292647

Inhibitory effect of Lactobacillus acidophilus on Helicobacter hepaticus in vitro.

Manhua Zhang1, Haiyang Zhang, Yan Li, Wenqian Qi, Xu Wang, Jiangbin Wang.   

Abstract

Helicobacter hepaticus and Helicobacter pylori both belong to Helicobacter species. Strains of Lactobacillus acidophilus, including L4 and L6, have shown significant inhibitory effects on H. pylori. Based on this phenomenon, we aim to investigate the inhibitory effect of L. acidophilus on H. hepaticus. Both standard and isolated H. hepaticus strains were grown under microaerophilic conditions at 37 °C in the presence of L. acidophilus supernatant, or lactic acid. The diameters of the inhibition zones were measured on the solid culture media. In liquid culture, the cell concentrations were measured and the urease activity was determined by phenol red staining. Sixteen strains of L. acidophilus isolated from human feces (named as L1-L16) showed anti-H. hepaticus effects. Two of them (L4 and L6) exhibited the most apparent effects on H. hepaticus inhibition. The L. acidophilus supernatant of L4 and L6 significantly increased the diameters of the inhibition zones compared with that of the lactic acid control (P < 0.05). The inhibitory role of L. acidophilus supernatant was independent of the pH value of solution (P > 0.05). Moreover, in liquid culture, L. acidophilus supernatant significantly reduced the cell growth rate and the urease activity of H. hepaticus cells in a time-dependent pattern (P < 0.05 compared with lactic acid control). No obvious difference was observed between the standard and isolated strain of H. hepaticus (P > 0.05). Our results indicate that L. acidophilus can decrease the viability and urease activity of H. hepaticus in vitro and this inhibition is independent of pH levels. This provides evidence for developing novel approaches for the prevention and treatment of H. hepaticus infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23292647     DOI: 10.1007/s11274-012-1203-2

Source DB:  PubMed          Journal:  World J Microbiol Biotechnol        ISSN: 0959-3993            Impact factor:   3.312


  33 in total

1.  Helicobacter species identified in liver from patients with cholangiocarcinoma and hepatocellular carcinoma.

Authors:  H O Nilsson; R Mulchandani; K G Tranberg; U Stenram; T Wadström
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

2.  Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model.

Authors:  A M Kabir; Y Aiba; A Takagi; S Kamiya; T Miwa; Y Koga
Journal:  Gut       Date:  1997-07       Impact factor: 23.059

3.  Post-natal development of the porcine microbiota composition and activities.

Authors:  Sergey R Konstantinov; Ajay A Awati; Barbara A Williams; Bevis G Miller; Philip Jones; Christopher R Stokes; Antoon D L Akkermans; Hauke Smidt; Willem M de Vos
Journal:  Environ Microbiol       Date:  2006-07       Impact factor: 5.491

4.  Prolonged survival and cytoplasmic pH homeostasis of Helicobacter pylori at pH 1.

Authors:  K Stingl; E M Uhlemann Em; G Deckers-Hebestreit; R Schmid; E P Bakker; K Altendorf
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

5.  Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria.

Authors:  M F Bernet; D Brassart; J R Neeser; A L Servin
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

6.  Helicobacter infection and cirrhosis in hepatitis C virus carriage: is it an innocent bystander or a troublemaker?

Authors:  A Ponzetto; R Pellicano; N Leone; M A Cutufia; F Turrini; W F Grigioni; A D'Errico; P Mortimer; M Rizzetto; L Silengo
Journal:  Med Hypotheses       Date:  2000-02       Impact factor: 1.538

7.  Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB.

Authors:  M H Coconnier; V Lievin; E Hemery; A L Servin
Journal:  Appl Environ Microbiol       Date:  1998-11       Impact factor: 4.792

8.  Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice.

Authors:  J G Fox; F E Dewhirst; J G Tully; B J Paster; L Yan; N S Taylor; M J Collins; P L Gorelick; J M Ward
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

9.  In vitro and in vivo inhibition of Helicobacter pylori by Lactobacillus casei strain Shirota.

Authors:  D Sgouras; P Maragkoudakis; K Petraki; B Martinez-Gonzalez; E Eriotou; S Michopoulos; G Kalantzopoulos; E Tsakalidou; A Mentis
Journal:  Appl Environ Microbiol       Date:  2004-01       Impact factor: 4.792

Review 10.  Bacterial infection as a cause of cancer.

Authors:  J Parsonnet
Journal:  Environ Health Perspect       Date:  1995-11       Impact factor: 9.031

View more
  4 in total

1.  Oral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses.

Authors:  Fan Hongying; Wu Xianbo; Yu Fang; Bai Yang; Long Beiguo
Journal:  Clin Vaccine Immunol       Date:  2013-11-27

Review 2.  Lactic acid bacteria: reviewing the potential of a promising delivery live vector for biomedical purposes.

Authors:  Olivia Cano-Garrido; Joaquin Seras-Franzoso; Elena Garcia-Fruitós
Journal:  Microb Cell Fact       Date:  2015-09-16       Impact factor: 5.328

3.  Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection.

Authors:  Andrea Fulgione; Nunzia Nocerino; Marco Iannaccone; Sante Roperto; Federico Capuano; Norberto Roveri; Marco Lelli; Antonio Crasto; Armando Calogero; Argenia Paola Pilloni; Rosanna Capparelli
Journal:  PLoS One       Date:  2016-07-06       Impact factor: 3.240

4.  Growth kinetic models of five species of Lactobacilli and lactose consumption in batch submerged culture.

Authors:  Fazlollah Rezvani; Fatemeh Ardestani; Ghasem Najafpour
Journal:  Braz J Microbiol       Date:  2017-01-03       Impact factor: 2.476

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.